Skoči na glavni sadržaj

Pregledni rad

The new therapeutic options in the treatment of spondiloarthritides

Porin PERIĆ ; Klinika za reumatske bolesti i rehabilitaciju Klinički bolnički centar Zagreb, Kišpatićeva 12, Zagreb


Puni tekst: hrvatski pdf 95 Kb

str. 104-110

preuzimanja: 281

citiraj

Puni tekst: engleski pdf 95 Kb

str. 104-110

preuzimanja: 325

citiraj


Sažetak

Therapeutic options for patients suffering from the more severe forms of SpA have been rather limited. The review focuses on the new therapeutic options in treatment spondyloarthritides. There is now clearly evidence that TNF-alpha inhibitors are effective and safe agents in managing psoriathic arthritis (PsA) and ankylosing spondylitis (AS).

Ključne riječi

biological agents; spondyloarthritides; TNF-alpha inhibitors

Hrčak ID:

129212

URI

https://hrcak.srce.hr/129212

Datum izdavanja:

28.7.2006.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.324 *